EU recommendations for 2024/2025 seasonal flu vaccine composition

26 March 2024 - EMA has issued recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for ...

Read more →

EU medicines agencies reflect on lessons learned from COVID-19

1 December 2023 - The European Medicines Regulatory Network has been at the forefront of the fight against COVID-19 with ...

Read more →

Paving the way towards coordinated clinical trials in public health emergencies in the EU

25 July 2023 - EMA has published a report from a workshop that collected insights and suggestions for possible EU level ...

Read more →

EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants

6 June 2023 - The European Centre for Disease Prevention and Control and the European Medicines Agency have issued a ...

Read more →

EMA and European medicines regulatory network lift COVID-19 business continuity status

10 May 2023 - EMA and the European medicines regulatory network are lifting their respective COVID-19 business continuity measures after successfully ...

Read more →

Statement from Emer Cooke on the end of the COVID-19 public health emergency

9 May 2023 - On Friday, the WHO Director General declared an end to the Public Health Emergency of International Concern ...

Read more →

ETF concludes that bivalent original/Omicron BA.4-5 mRNA vaccines may be used for primary vaccination

6 December 2022 - EMA’s Emergency Task Force considers that adapted mRNA bivalent vaccines targeting the original strain and Omicron ...

Read more →

EU health regulator says COVID pandemic not over

20 September 2022 - An official at the European Union's drugs regulator said on Tuesday the COVID-19 pandemic was not ...

Read more →

Take whatever COVID booster you can get, says head of EU drugs watchdog

14 September 2022 - People in Europe should take whatever COVID-19 booster is available to them in the coming months, ...

Read more →

ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines

6 September 2022 - The European Centre for Disease Prevention and Control and the European Medicines Agency have issued a ...

Read more →

EMA’s Emergency Task Force advises on intradermal use of Imvanex/Jynneos against monkeypox

19 August 2022 - EMA’s Emergency Task Force (ETF) has reviewed data on the monkeypox vaccine Imvanex  used as an ...

Read more →

Big data use for public health: publication of Big Data Steering Group workplan 2022-25

28 July 2022 - The Big Data Steering Group set up by EMA and the Heads of Medicines Agencies has ...

Read more →

EMA response to the monkeypox public health emergency

27 July 2022 - The EMA has initiated a series of actions to respond to the ongoing monkeypox outbreak, which ...

Read more →

ECDC and EMA update recommendations on additional booster doses of mRNA COVID-19 vaccines

11 July 2022 - The European Centre for Disease Prevention and Control and the EMA are recommending that second booster ...

Read more →

Global regulators agree on key principles on adapting vaccines to tackle virus variants

1 July 2022 - On 30 June, regulators from around the world discussed emerging evidence to support adaptation of COVID-19 ...

Read more →